0001209191-21-064771.txt : 20211116 0001209191-21-064771.hdr.sgml : 20211116 20211116163418 ACCESSION NUMBER: 0001209191-21-064771 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211112 FILED AS OF DATE: 20211116 DATE AS OF CHANGE: 20211116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Hunter C CENTRAL INDEX KEY: 0001636385 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37722 FILM NUMBER: 211416589 MAIL ADDRESS: STREET 1: C/O GENESEE & WYOMING INC. STREET 2: 20 WEST AVENUE CITY: DARIEN STATE: CT ZIP: 06820 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: (512) 942-2935 MAIL ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-11-12 0 0001636282 Aeglea BioTherapeutics, Inc. AGLE 0001636385 Smith Hunter C C/O AEGLEA BIOTHERAPEUTICS, INC. 805 LAS CIMAS PARKWAY, SUITE 100 AUSTIN TX 78746 1 0 0 0 Director Stock Option (right to buy) 7.04 2021-11-12 4 A 0 60000 0.00 A 2031-11-11 Common Stock 60000 60000 D The stock option vests and becomes exercisable in 36 equal monthly installments beginning on December 12, 2021 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. /s/ Steven Weber, by power of attorney 2021-11-16